Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of MK-7655 + imipenem/cilastatin versus imipenem/cilastatin in complicated intra-abdominal infection
2011-005686-20Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of relebactam, imipenem, cilastatin in Intra-abdominal infection (IAI), sponsored by Merck & Co.. Started Feb 2012; status: completed.
02
Drugs
relebactamimipenemcilastatin
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2011-005686-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005686-20.